BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26666922)

  • 21. Respiratory syncytial virus: prospects for new and emerging therapeutics.
    Jorquera PA; Tripp RA
    Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
    DeVincenzo JP; Hall CB; Kimberlin DW; Sánchez PJ; Rodriguez WJ; Jantausch BA; Corey L; Kahn JS; Englund JA; Suzich JA; Palmer-Hill FJ; Branco L; Johnson S; Patel NK; Piazza FM
    J Infect Dis; 2004 Sep; 190(5):975-8. PubMed ID: 15295704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon.
    Abou-El-Hassan H; Massaad E; Soudani N; Assaf-Casals A; Shaker R; Lteif Khoury M; Ghanem S; Karam M; Andary R; Saito R; Dbaibo G; Zaraket H
    PLoS One; 2019; 14(2):e0212687. PubMed ID: 30789963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Dunn MC; Knight DA; Waldman WJ
    Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
    Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
    Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.
    Lundin A; Bergström T; Trybala E
    Methods Mol Biol; 2013; 1030():345-63. PubMed ID: 23821281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Gaillard V; Galloux M; Garcin D; Eléouët JF; Le Goffic R; Larcher T; Rameix-Welti MA; Boukadiri A; Héritier J; Segura JM; Baechler E; Arrell M; Mottet-Osman G; Nyanguile O
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
    Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
    Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
    King T; Mejias A; Ramilo O; Peeples ME
    PLoS Pathog; 2021 Apr; 17(4):e1009469. PubMed ID: 33831114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection.
    Sun Z; Wang Q; Jia R; Xia S; Li Y; Liu Q; Xu W; Xu J; Du L; Lu L; Jiang S
    Viruses; 2015 Feb; 7(2):798-819. PubMed ID: 25690799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies.
    Shang Z; Tan S; Ma D
    Int J Biol Sci; 2021; 17(14):4073-4091. PubMed ID: 34671221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors.
    Yamaguchi-Sasaki T; Tamura Y; Ogata Y; Kawaguchi T; Kurosaka J; Sugaya Y; Iwakiri K; Busujima T; Takahashi R; Ueda-Yonemoto N; Tanigawa E; Abe-Kumasaka T; Sugiyama H; Kanuma K
    Chem Pharm Bull (Tokyo); 2020; 68(4):345-362. PubMed ID: 32238652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Epidemiologic Characteristics of Hospitalized Patients with Laboratory-Confirmed Respiratory Syncytial Virus Infection in Eastern China between 2009 and 2013: A Retrospective Study.
    Cui D; Feng L; Chen Y; Lai S; Zhang Z; Yu F; Zheng S; Li Z; Yu H
    PLoS One; 2016; 11(11):e0165437. PubMed ID: 27802292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
    J Virol; 2016 Jan; 90(1):245-53. PubMed ID: 26468535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.